Effects of etomidate on vasopressor use in patients with sepsis or severe sepsis: A propensity-matched analysis

Journal of Critical Care

Volumn 29, Issue 4, 2014, Pages 517-522

  Alday, Nerissa J ^b   Jones, G Morgan ^c   Kimmons, Lauren A ^c   Phillips, Gary S ^d   McCallister, Jennifer W ^a,e   Doepker, Bruce A ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c METHODIST UNIVERSITY HOSPITAL   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

Adrenal insufficiency; Etomidate; Hypotension; Sepsis; Vasopressor

Indexed keywords

ADRENALIN; DOPAMINE; ETOMIDATE; FENTANYL; HYPERTENSIVE AGENT; KETAMINE; MIDAZOLAM; NEUROMUSCULAR BLOCKING AGENT; NORADRENALIN; PHENYLEPHRINE; PROPOFOL; VASOPRESSIN; INTRAVENOUS ANESTHETIC AGENT; VASOCONSTRICTOR AGENT;

ADULT; ANESTHESIA INDUCTION; ARTICLE; BOLUS INJECTION; COHORT ANALYSIS; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; HYPOTENSION; INCIDENCE; INTENSIVE CARE UNIT; INTUBATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; SEPSIS; SEPTIC SHOCK; SINGLE DRUG DOSE; ADRENAL GLAND; AGED; CASE CONTROL STUDY; CLINICAL TRIAL; DRUG EFFECTS; METABOLISM; MULTICENTER STUDY; PROPENSITY SCORE;

ADRENAL GLANDS; ADULT; AGED; ANESTHETICS, INTRAVENOUS; CASE-CONTROL STUDIES; COHORT STUDIES; ETOMIDATE; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; PROPENSITY SCORE; RETROSPECTIVE STUDIES; SEPSIS; VASOCONSTRICTOR AGENTS;

EID: 84902297920     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2014.02.002     Document Type: Article

References (23)

1. Amidate (etomidate) injection [package insert] November 2009, Hospira Inc., Lake Forest, IL.
2. Jackson W.L. Should we use etomidate as an induction agent in patients with septic shock. Chest 2005, 127:1031-1038.
3. Forman S.A. Clinical and molecular pharmacology of etomidate. Anesthesiology 2011, 114:695-707.
4. Absalom A., Pledger D., Kong A. Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia 1999, 54:861-867.
5. Bloomfield R., Noble D.W. Etomidate and fatal outcome-even a single bolus dose may be detrimental for some patients. Br J Anaesth 2006, 97:116-117.
6. Vinclair M., Broux C., Faure P., Brun J., Genty C., Jacquot C., et al. Duration of adrenal inhibition following a single dose of etomidate in critically ill patients. Intensive Care Med 2008, 34:714-719.
7. Dmello D., Taylor S., O'Brien J., Matuschak G.M. Outcomes of etomidate in severe sepsis and septic shock. Chest 2010, 138:1327-1332.
8. Annane D., Sebille V., Charpentier C., Bollaert P., Francois B., Korach J., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisones on mortality in patients with septic shock. JAMA 2002, 288(7):862-871.
9. Sprung C.L., Annane D., Keh D., Moreno R., Singer M., Freivogel K., et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008, 358:111-124.
10. Lipiner-Friedman D., Sprung C.L., Laterre P.F., Weiss Y., Goodman S., Vogeser M., et al. Adrenal function in sepsis: the retrospective CORTICUS cohort study. Crit Care Med 2007, 35:1012-1018.
11. Cuthbertson B.H., Sprung C.L., Annane D., Chevret S., Garfield M., Goodman S., et al. The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med 2009, 35:1868-1876.
12. Chan C.M., Mitchell A.L., Shorr A.F. Etomidate is associated with mortality and adrenal insufficiency in sepsis: a meta-analysis. Crit Care Med 2012, 40:2945-2953.
13. Ehrman R., Wira C., Lomax A., Hayward A., Marcelin J., Ellis T., et al. Etomidate use in severe sepsis and septic shock patients does not contribute to mortality. Intern Emerg Med 2011, 6:253-257.
14. Diaz-Guzman E., Mireles-Cabodevila E., Heresi G.A., Bauer S., Arroliga A. A comparison of methohexital versus etomidate for endotracheal intubation of critically ill patients. Am J Crit Care 2010, 19:48-54.
15. Jabre P., Combes X., Lapostolle F., Dhaouadi M., Ricard-Hibon A., Vivien B., et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet 2009, 374:293-300.
16. Ray D.C., McKeown D.W. Effect of induction agent on vasopressor and steroid use and outcome in patients with septic shock. Crit Care 2007, 11:R56.
17. Annane D. Etomidate and intensive care physicians. Intensive Care Med 2005, 31(10):1454.
18. Bone R.C., Balk R.A., Cerra F.B., Dellinger R., Fein A., Knaus W., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101(6):1644-1655.
19. Dellinger R., Levy M., Carlet J., Bion J., Parker M., Jaeschke R., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36(1):296-327.
20. American Thoracic Society, Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416.
21. Gaieski D.F., Mikkelsen M.E., Band R.A., Pines J., Massone R., Furia F., et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 2010, 38(4):1045-1053.
22. Leuven E., Sianesi B. PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing. Statistical Software Components S432001, Boston College Department of Economics 2003, [revised 19 Apr 2012. Available at: http://ideas.repec.org/c/boc/bocode/s432001.html. Accessibility verified June 12, 2012].
23. Payen J., Dupuis C., Trouve-Buisson T., Vinclair M., Bouzat P., Genty C., et al. Corticosteroid after etomidate in critically ill patients: a randomized controlled trial. Crit Care Med 2012, 40(1):29-35.